During the course of the hospital stay, Noah Martin demonstrated a gradual improvement in respiratory status, which was carefully monitored and managed by the healthcare team. The treatment provided to the patient was in line with established medical guidelines and was essential for the patient's recovery and well-being. On January 16, Noah Martin was admitted to the Emergency Department with a COPD exacerbation. The patient complained of increased shortness of breath, difficulty taking PO, and appeared hunched over with increased work of breathing. The initial treatment included administering a short-acting beta-agonist (SABA) and systemic steroids, as well as monitoring respiratory status and O2 saturation. On January 17, the patient reported a slight improvement in breathing but still experienced shortness of breath. O2 saturation was at 90%, and the treatment plan was adjusted to include the consideration of adding a long-acting beta-agonist (LABA). On January 18, Noah Martin reported further improvement in breathing, with O2 saturation improving to 92% and arterial blood gas (ABG) at 61 mmHg. The patient's respiratory rate decreased, and accessory muscle use diminished.